psyllium has been researched along with lisinopril in 1 studies
| Studies (psyllium) | Trials (psyllium) | Recent Studies (post-2010) (psyllium) | Studies (lisinopril) | Trials (lisinopril) | Recent Studies (post-2010) (lisinopril) |
|---|---|---|---|---|---|
| 731 | 177 | 216 | 2,210 | 648 | 491 |
| Protein | Taxonomy | psyllium (IC50) | lisinopril (IC50) |
|---|---|---|---|
| Angiotensin-converting enzyme | Homo sapiens (human) | 0.0021 | |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 0.287 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0012 | |
| Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 0.0012 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Semwal, DK; Semwal, R; Semwal, RB | 1 |
1 other study(ies) available for psyllium and lisinopril
| Article | Year |
|---|---|
A gastroretentive drug delivery system of lisinopril imbibed on isabgol-husk.
Topics: Angiotensin-Converting Enzyme Inhibitors; Drug Delivery Systems; Excipients; Hypromellose Derivatives; Lisinopril; Psyllium; Solubility | 2014 |